Friday, December 12, 2025 | 10:52 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Race for vaccine against coronavirus heats up in India; 6 firms in the fray

With vaccines of some firms already in the animal trial phase, developers say that if all goes well, India can have a vaccine by next year, ahead of the earlier timelines

testing, private laboratories, labs, vaccines, doctors, nurses, health, coronavirus
premium

Indian players are working round the clock to ensure they have a candidate fast.

Sohini Das Mumbai
As Chinese research firm may have made news by becoming the first organisation globally to enter phase-II of clinical trials to find a vaccine against the novel coronavirus disease (Covid-19) but Indian drugmakers are not far behind.
 
Six Indian drugmakers are in race to make a Covid-19 vaccine and, on basis of what these developers say, India may have a vaccine by next year as most candidates are already in animal-trial phase.
 
Gagandeep Kang, the vice-chair of the Coalition for Epidemic Preparedness Innovations, said Cadila Healthcare (Zydus Cadila), Serum Institute of India, Bharat Biotech, Indian Immunologicals, Mynvax, and Biological E